In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic®, Wegovy®)and tirzepatide (Mounjaro®), have become among the most widely used medications for the...

The U.S. Food and Drug Administration (FDA) has officially approved the next-generation ROS1-selective inhibitor zidesamtinib (Jideytro) for the treatment of adult patients with locally...

Semaglutide is considered one of the most effective medications in modern medicine for the management of obesity and type 2 diabetes. However, its high...

The first bone marrow transplantation procedure has been successfully performed in Adjara. The bone marrow transplantation service has been launched at Batumi University Hospital,...

GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide, are currently considered among the most effective pharmacotherapies for the management of obesity....

Researchers at the University of Texas Health Science Center at San Antonio (UT Health San Antonio) have identified a potential pathophysiological link between the...

Obesity and overweight represent a critical challenge to contemporary public health. Although the body mass index (BMI) has served as the standard tool for...

Crown Princess Mette-Marit of Norway, who has been battling pulmonary fibrosis since 2018, has been registered on the national lung transplant waiting list due...